Wojciech Biernat
Overview
Explore the profile of Wojciech Biernat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
205
Citations
2371
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sakowska J, Glasner P, Dukat-Mazurek A, Rydz A, Zielinski M, Pellowska I, et al.
Transpl Immunol
. 2023 May;
79:101852.
PMID: 37196866
Background: Corneal transplantations (CTXs) are a vision-saving procedure. Routinely, while CTXs' survival rates remain high, the risk of graft failure increases significantly for repeated CTXs. The reason is an alloimmunization...
12.
Baneckova M, Thompson L, Hyrcza M, Vanecek T, Agaimy A, Laco J, et al.
Am J Surg Pathol
. 2023 Apr;
47(6):661-677.
PMID: 37070739
Salivary gland secretory carcinoma (SC), previously mammary analog SC, is a low-grade malignancy characterized by well-defined morphology and an immunohistochemical and genetic profile identical to SC of the breast. Translocation...
13.
Fiwek P, Irga-Jaworska N, Wojtylak S, Biernat W, Emerich K, Pomiecko D
J Clin Med
. 2023 Apr;
12(7).
PMID: 37048748
Background And Objectives: The primary objective of the undertaken study was to determine the morphological changes that occur within the oral epithelium in children undergoing chemotherapy following a diagnosis of...
14.
Kunc M, Zemierowska N, Skowronek F, Biernat W
Histopathology
. 2023 Mar;
83(1):3-14.
PMID: 36942814
PRAME is a novel immunohistochemical marker that aids the diagnosis of melanocytic lesions. Diffuse PRAME positivity suggests melanoma, whereas benign naevi are negative or only weakly positive. However, the factual...
15.
Khan I, Gril B, Paranjape A, Robinson C, Difilippantonio S, Biernat W, et al.
Mol Cancer Ther
. 2023 Mar;
22(5):646-658.
PMID: 36912773
Advances in drug treatments for brain metastases of breast cancer have improved progression-free survival but new, more efficacious strategies are needed. Most chemotherapeutic drugs infiltrate brain metastases by moving between...
16.
Jasiak A, Koczkowska M, Stukan M, Wydra D, Biernat W, Izycka-Swieszewska E, et al.
Exp Mol Pathol
. 2023 Feb;
130:104856.
PMID: 36791903
Background: The mRNA splicing is regulated on multiple levels, resulting in the proper distribution of genes' transcripts in each cell and maintaining cell homeostasis. At the same time, the expression...
17.
Inaguma S, Ueki A, Lasota J, Komura M, Sheema A, Czapiewski P, et al.
J Pathol Clin Res
. 2023 Feb;
9(3):195-207.
PMID: 36754859
Diffuse pleural mesothelioma (PM) is a highly aggressive tumour typically associated with short survival. Recently, the effectiveness of first-line immune checkpoint inhibitors in patients with unresectable PM was reported. CD70-CD27...
18.
Peters S, Letovanec I, Mauer M, Dafni U, Ejedepang D, Biernat W, et al.
Lung Cancer
. 2022 Dec;
175:141-151.
PMID: 36535121
Background: The primary objective of this study is to evaluate the clinical significance of RANK/L expression, in both a retrospective cohort of surgically resected stage I-III NSCLC (Lungscape) and a...
19.
Duchnowska R, Supernat A, Peksa R, Lukasiewicz M, Stokowy T, Ronen R, et al.
Sci Rep
. 2022 Nov;
12(1):20537.
PMID: 36446793
Brain metastases (BMs) in ovarian cancer (OC) are a rare event. BMs occur most frequently in high-grade serous (HGS) OC. The molecular features of BMs in HGSOC are poorly understood....
20.
Peksa R, Kunc M, Bienkowski M, Popeda M, Biernat W
Pol J Pathol
. 2022 Nov;
73(2):159-165.
PMID: 36345953
Terminal deoxynucleotidyl transferase (TdT) is a unique type of DNA polymerase predominantly expressed in precursor lymphoid cells and acute lymphoblastic leukemia. It participates in the junctional diversity of T-cell receptors...